8.55 AM CET (Central Europe)
Welcome and webinar instructions.
Please join the webinar to make sure the connection works.
9.00 - 10.00 AM CET (Central Europe)
Regulatory perspectives on probiotics and microbiome products
Speaker:
Atte von Wright, Professor Emeritus, Scientific Advisor at Biosafe
Over the past decade, our understanding of the composition and functions of the human gastrointestinal microbiota has advanced rapidly. We know now that gut bacteria influence host functions both directly and via their metabolites. These insights are reshaping how probiotics, postbiotics (non-viable microbes or their components), and prebiotics are understood, assessed, and developed.
The consumption of live or even dead bacteria to improve human or animal health and wellbeing is increasingly supported by solid scientific evidence, while also raising new questions for safety assessment, efficacy, and regulation. In parallel, new insights into prebiotics, substrates that selectively promote the growth or activity of beneficial microbial groups, are helping to better define their role in the microbiome and in health outcomes.
In this webinar series, Biosafe brings a scientific and regulatory perspective to the evolving microbiome landscape. We explore what current research really tells us, where uncertainties remain, and what companies need to consider when developing and introducing new probiotic, prebiotic, or postbiotic formulations for food, feed, or supplements.
Webinar 3/3: Regulatory perspectives on probiotics and microbiome products
How products targeting the microbiome are classified, assessed, and authorised.
-
Foods, novel foods or pharmaceuticals? Regulatory positioning
-
Health claims in the EU: what is allowed and why
-
When is a product considered a novel food?
-
How the safety of a probiotic is assessed in practice
